From this data emerges the high frequency of variants identified in the ATM gene, as well as in BRCA1 and BRCA2, in patients with BC and the high contribution of variants localized in the 3′UTR of PTEN in patients with multiple tumors. This evidence concerns the gene PTEN and breast cancer.